| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/26/2012 | US20120190561 Means and methods for diagnosing endometriosis |
| 07/26/2012 | US20120190017 Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (mrp-1) and their use in diagnostic and therapeutic applications |
| 07/26/2012 | US20120189648 Infectious hepatitis c viruses of genotype 3a and 4a and uses thereof |
| 07/26/2012 | US20120189643 Toll Like Receptor 3 Antagonists, Methods and Uses |
| 07/26/2012 | US20120189640 Methods and Compositions Related to Soluble Monoclonal Variable Lymphocyte Receptors of Defined Antigen Specificity |
| 07/26/2012 | US20120189639 Anti-gitr antibodies |
| 07/26/2012 | US20120189636 Human serum amyloid-a3 antibody and use thereof |
| 07/26/2012 | US20120189633 Anti-kit antibodies and uses thereof |
| 07/26/2012 | US20120189630 BISPECIFIC EGFRvIII ANTIBODY ENGAGING MOLECULES |
| 07/26/2012 | US20120189628 Anti-il-tif antibodies and methods of using in inflammation |
| 07/26/2012 | US20120189622 Anti-cd38 human antibodies and uses thereof |
| 07/26/2012 | US20120189617 Anti-tim-3 antibody |
| 07/26/2012 | US20120189541 Dual Variable Domain Immunnoglobulins and Uses Thereof |
| 07/26/2012 | US20120189540 IL3Ralpha Antibody Conjugates And Uses Thereof |
| 07/26/2012 | CA2824885A1 Binding proteins to inhibitors of coagulation factors |
| 07/26/2012 | CA2824719A1 Anti-il1rap antibodies and their use for treating human |
| 07/26/2012 | CA2823707A1 Nav1.7 knockout mice and uses thereof |
| 07/25/2012 | EP2479566A2 Predictive renal safety biomarkers and biomarker signatures to monitor kidney function |
| 07/25/2012 | EP2479277A2 Compositions and methods of use for MGD-CSF in disease treatment |
| 07/25/2012 | EP2479192A1 Compositions and Methods for Diagnosing and Treating Cancer |
| 07/25/2012 | EP2479191A2 Improved nanobodiesTM against tumor necrosis factor-alpha |
| 07/25/2012 | EP2479190A1 Collagen neoepitope antibody |
| 07/25/2012 | EP2478917A1 SP35 antibodies and uses thereof |
| 07/25/2012 | EP2478912A1 Auristatin conjugates with anti-HER2 or anti-CD22 antibodies and their use in therapy |
| 07/25/2012 | EP2478368A1 Immunological assay and immunological assay kit |
| 07/25/2012 | EP2478136A2 Libraries of genetic packages comprising novel hc cdr3 designs |
| 07/25/2012 | EP2478110A1 Class i anti-cea antibodies and uses thereof |
| 07/25/2012 | EP2478104A1 Antibody fusion-mediated plant resistance against oomycota |
| 07/25/2012 | EP2478014A1 Fusion polypeptides and uses thereof |
| 07/25/2012 | EP2478013A2 Coiled coil and/or tether containing protein complexes and uses thereof |
| 07/25/2012 | EP2478012A1 Treatment of autoimmune and inflammatory diseases with epratuzumab |
| 07/25/2012 | EP2477658A2 Hiv-1 antibodies |
| 07/25/2012 | EP2477657A1 Diagnostic and therapeutic uses of soluble fc-epsilon receptor i for ige-mediated disorders |
| 07/25/2012 | EP2477656A1 Treatment of neurological conditions |
| 07/25/2012 | EP2477655A2 Vaccines directed to langerhans cells |
| 07/25/2012 | EP2477654A1 Methods for treating psoriasis |
| 07/25/2012 | EP2477653A1 Dosage regimen for administering an epcamxcd3 bispecific antibody |
| 07/25/2012 | EP2477648A1 Synergistic anti-cd47 therapy for hematologic cancers |
| 07/25/2012 | EP2477603A2 Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof |
| 07/25/2012 | EP2444492A9 Chicken-derived anti-lox-1 antibody |
| 07/25/2012 | EP1979378B1 Novel collection of hcdr3 regions and uses therefor |
| 07/25/2012 | EP1711531B9 Neutralizing anti tlr4/md-2 antibodies and methods of use thereof |
| 07/25/2012 | EP1592457B1 Folate-vinblastine conjugate as medicament |
| 07/25/2012 | EP1558276B1 Flaviviris fusion inhibitors |
| 07/25/2012 | EP1423701B1 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 07/25/2012 | EP1080111B1 The induction of antiobiotic peptides by lait (scd14) protein |
| 07/25/2012 | CN102612559A Modified peptide vaccine derived from influenza m2 |
| 07/25/2012 | CN102612524A Dual variable domain immunoglobulins and uses thereof |
| 07/25/2012 | CN102612374A A method of promoting dendritic spine density |
| 07/25/2012 | CN102608332A Enzyme-linked immunoassay (ELISA) method of grass carp interleukin 10 |
| 07/25/2012 | CN102608331A Colloidal gold labeled quick-diagnosis test strip for virulent strains and low-virulent strains of Newcastle disease |
| 07/25/2012 | CN102605062A Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 07/25/2012 | CN102603895A Novel antigen-binding polypeptides and their uses |
| 07/25/2012 | CN102603894A Interferon alpha receptor 1 antibodies and their uses |
| 07/25/2012 | CN102603893A Method of providing disease-specific binding molecules and targets |
| 07/25/2012 | CN102603892A Tumor marker FOXP3 auto-antibody and application thereof |
| 07/25/2012 | CN102603891A Method for preparing tetanus human immune globulin by double virus inactivation |
| 07/25/2012 | CN101955531B Antibody for detecting porcine reproductive and respiratory syndrome virus |
| 07/25/2012 | CN101891818B Single-chain antibody in anti-human prostate-specific membrane antigen extracellular region and application thereof |
| 07/25/2012 | CN101797384B Tri-union compound immunopotentiator and method for preparing same |
| 07/25/2012 | CN101759800B Preparation of dirhamnolipid artificial antigen and antibody, enzyme-linked immunity test paper, preparation and detection method thereof |
| 07/25/2012 | CN101622342B Cancerous disease modifying antibodies |
| 07/25/2012 | CN101506239B Antihuman alpha9 integrin antibody and use of the same |
| 07/25/2012 | CN101506235B Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals |
| 07/25/2012 | CN101445557B Cadmium ion antigen and preparation method and application thereof |
| 07/25/2012 | CN101346394B TGF-beta binding compositions |
| 07/25/2012 | CN101120018B Human monoclonal antibody specific for lipopolysaccharides (LPS) of the pseudomonas aeruginosa IATS O11 serotype |
| 07/25/2012 | CN101029308B Plant derived molecule, genetic coding sequence and its uses |
| 07/24/2012 | US8227585 Human mini-antibody cytotoxic for tumor cells which express the ERBB2 receptor |
| 07/24/2012 | US8227584 Ostertagia vaccine |
| 07/24/2012 | US8227580 Human monoclonal antibodies to epidermal growth factor receptor |
| 07/24/2012 | US8227578 Anti-human dlk-1 antibody showing anti-tumor activity in vivo |
| 07/24/2012 | US8227576 Antibodies against amyloid-β peptide |
| 07/24/2012 | US8227575 Cytokine zalpha11 ligand antibodies |
| 07/24/2012 | US8227570 Modified gherlin peptides |
| 07/24/2012 | US8227413 Compositions and methods for inducing angiogenesis |
| 07/24/2012 | US8227410 Methods of stimulating wound healing by administration of vascular endothelial growth factor D (VEGF-D) |
| 07/24/2012 | US8227213 β1,3-N-acetyl-D-galactosamine transferase protein, nucleic acid encoding the same and method of examining canceration using the same |
| 07/24/2012 | US8227211 Humanized anti-CCR2 antibodies and methods of use therefor |
| 07/24/2012 | US8227200 Methods for identifying kremen polypeptide binding partners |
| 07/24/2012 | US8227194 Monoclonal antibodies with binding specificity for response gene to complement 32 (RGC-32) |
| 07/24/2012 | US8227190 Approach to molecular diagnosis of human papillomavirus-related diseases |
| 07/24/2012 | US8227185 Non-M, non-O HIV-1 strains, fragments and uses |
| 07/24/2012 | US8226976 Method of using cell-free protein synthesis to produce a membrane protein |
| 07/24/2012 | US8226958 Modified SEB and prophylactics/remedies for immunopathy containing the same |
| 07/24/2012 | US8226955 Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes |
| 07/24/2012 | US8226953 Group B Streptococcus antigens |
| 07/24/2012 | US8226951 Methods for treating bone cancer by administering a nerve growth factor antagonist antibody |
| 07/24/2012 | US8226950 Recombinant anti-VLA4 antibody molecules |
| 07/24/2012 | US8226947 Interleukin-10 antibodies |
| 07/24/2012 | US8226945 Antibodies and immunoconjugates and uses therefor |
| 07/24/2012 | US8226943 Antibodies to notch receptors |
| 07/24/2012 | US8226935 ErbB2 and ErbB3 chimeric heteromultimer receptors |
| 07/24/2012 | US8226611 Anti-IL-6 antibodies, compositions, methods and uses |
| 07/24/2012 | CA2486252C Methods for screening for agents that modulate hepatocellular carcinoma development |
| 07/24/2012 | CA2438334C Ocular tear growth factor-like protein |
| 07/19/2012 | WO2012097333A2 Aldehyde-tagged immunoglobulin polypeptides and method of use thereof |
| 07/19/2012 | WO2012097084A2 Tenomodulin (tnmd) isoforms and uses thereof |
| 07/19/2012 | WO2012095662A1 Antibody molecules which bind il-17a and il-17f |
| 07/19/2012 | WO2012095535A1 Methods for the identification and repair of amino acid residues destabilizing single-chain variable fragments (scfv) |